China · Delayed Price · Currency is CNY Runben Biotechnology Statistics
Total Valuation
SHA:603193 has a market cap or net worth of CNY 6.92 billion. The enterprise value is 5.48 billion.
| Market Cap | 6.92B |
| Enterprise Value | 5.48B |
Important Dates
The last earnings date was Tuesday, October 20, 2026.
| Earnings Date | Oct 20, 2026 |
| Ex-Dividend Date | Sep 21, 2026 |
Share Statistics
SHA:603193 has 404.59 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 404.59M |
| Shares Outstanding | 404.59M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +3.43% |
| Owned by Insiders (%) | 29.19% |
| Owned by Institutions (%) | 2.80% |
| Float | 82.23M |
Valuation Ratios
The trailing PE ratio is 19.87 and the forward PE ratio is 18.74.
| PE Ratio | 19.87 |
| Forward PE | 18.74 |
| PS Ratio | 4.09 |
| PB Ratio | 3.05 |
| P/TBV Ratio | 3.16 |
| P/FCF Ratio | 31.99 |
| P/OCF Ratio | 21.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.24, with an EV/FCF ratio of 25.41.
| EV / Earnings | 15.98 |
| EV / Sales | 3.25 |
| EV / EBITDA | 14.24 |
| EV / EBIT | 15.10 |
| EV / FCF | 25.41 |
Financial Position
The company has a current ratio of 14.10, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.10 |
| Quick Ratio | 12.69 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | 8,724.60 |
Financial Efficiency
Return on equity (ROE) is 15.58% and return on invested capital (ROIC) is 38.43%.
| Return on Equity (ROE) | 15.58% |
| Return on Assets (ROA) | 9.75% |
| Return on Invested Capital (ROIC) | 38.43% |
| Return on Capital Employed (ROCE) | 15.99% |
| Weighted Average Cost of Capital (WACC) | 5.25% |
| Revenue Per Employee | 1.68M |
| Profits Per Employee | 342,378 |
| Employee Count | 1,018 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 4.98 |
Taxes
In the past 12 months, SHA:603193 has paid 46.97 million in taxes.
| Income Tax | 46.97M |
| Effective Tax Rate | 11.88% |
Stock Price Statistics
The stock price has decreased by -34.60% in the last 52 weeks. The beta is 0.18, so SHA:603193's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -34.60% |
| 50-Day Moving Average | 20.03 |
| 200-Day Moving Average | 22.03 |
| Relative Strength Index (RSI) | 33.35 |
| Average Volume (20 Days) | 3,598,641 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603193 had revenue of CNY 1.71 billion and earned 348.54 million in profits. Earnings per share was 0.86.
| Revenue | 1.71B |
| Gross Profit | 1.03B |
| Operating Income | 368.85M |
| Pretax Income | 395.52M |
| Net Income | 348.54M |
| EBITDA | 389.94M |
| EBIT | 368.85M |
| Earnings Per Share (EPS) | 0.86 |
Balance Sheet
The company has 1.44 billion in cash and 355,960 in debt, with a net cash position of 1.44 billion or 3.56 per share.
| Cash & Cash Equivalents | 1.44B |
| Total Debt | 355,960 |
| Net Cash | 1.44B |
| Net Cash Per Share | 3.56 |
| Equity (Book Value) | 2.30B |
| Book Value Per Share | 5.69 |
| Working Capital | 1.53B |
Cash Flow
In the last 12 months, operating cash flow was 320.92 million and capital expenditures -101.76 million, giving a free cash flow of 219.16 million.
| Operating Cash Flow | 320.92M |
| Capital Expenditures | -101.76M |
| Depreciation & Amortization | 21.09M |
| Net Borrowing | -1.52M |
| Free Cash Flow | 219.16M |
| FCF Per Share | 0.54 |
Margins
Gross margin is 60.09%, with operating and profit margins of 21.53% and 20.34%.
| Gross Margin | 60.09% |
| Operating Margin | 21.53% |
| Pretax Margin | 23.08% |
| Profit Margin | 20.34% |
| EBITDA Margin | 22.76% |
| EBIT Margin | 21.53% |
| FCF Margin | 12.79% |
Dividends & Yields
This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 3.16%.
| Dividend Per Share | 0.54 |
| Dividend Yield | 3.16% |
| Dividend Growth (YoY) | 25.58% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 62.21% |
| FCF Payout Ratio | 99.69% |
| Buyback Yield | -0.70% |
| Shareholder Yield | 2.47% |
| Earnings Yield | 5.03% |
| FCF Yield | 3.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHA:603193 is 29.85, which is 74.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 29.85 |
| Price Target Difference | 74.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 18.17% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603193 has an Altman Z-Score of 49.09 and a Piotroski F-Score of 6.
| Altman Z-Score | 49.09 |
| Piotroski F-Score | 6 |